Min-Sung Sean Kim

Min-Sung is a Managing Partner at Digital Health Ventures (DHV), a specialized Venture Capital fund based in Berlin. Min-Sung’s international investment experience ranges from early-stage, to late-stage, and fund investments. Most recently, he headed the Berlin office of Samsung Catalyst Fund and was instrumental to the formation of the strategic growth fund of AllianzX (USD 1bn assets under management).

Min-Sung is passionate about opportunities in the healthcare sector and believes in both the immense value creation potential through digital technologies as well as the resulting positive impact on society. Having been an entrepreneur before, he understands the challenges and difficulties of building up a company.

Since 2013, he has invested in Digital Health companies, including mySugr, NeuroNation, Mimi, Medbelle, hi.health and Amwell, which went public in 2020.

Min-Sung studied Business Economics at Witten/Herdecke, Harvard, St.Gallen, and in Seoul.